Stay updated on EDP-305 Safety and Efficacy in NASH Clinical Trial
Sign up to get notified when there's something new on the EDP-305 Safety and Efficacy in NASH Clinical Trial page.

Latest updates to the EDP-305 Safety and Efficacy in NASH Clinical Trial page
- Check3 days agoChange DetectedThe NIH announcement about the terminology transition from “Artificial Intelligence” to “Super Intelligence,” along with links to updates and FAQs, is no longer displayed.SummaryDifference1%

- Check10 days agoChange DetectedThe footer now identifies the ClinicalTrials.gov site revision as v3.8.0 instead of v3.7.2. The study record remains inaccessible behind a 403 error.SummaryDifference0.2%

- Check17 days agoChange DetectedA banner announces NIH website transition updates and says both “Super Intelligence” and “Artificial Intelligence” may appear during the transition.SummaryDifference1%

- Check24 days agoChange DetectedThe site footer revision changed from v3.7.1 to v3.7.2 while the study page continues to show a 403 error.SummaryDifference0.2%

- Check31 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check52 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study record details. The header and footer of ClinicalTrials.gov remain visible, indicating restricted access to the study entry.SummaryDifference19%

Stay in the know with updates to EDP-305 Safety and Efficacy in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EDP-305 Safety and Efficacy in NASH Clinical Trial page.